Ag@AgCl nanoparticles grafted on carbon nanofiber: an efficient visible light plasmonic photocatalyst via bandgap reduction

A novel silver@silver chloride/carbon nanofiber (Ag@AgCl/CNF) hybrid was synthesized by electrospinning, heat treament, and subsequent in situ chemical oxidation strategy. The synthesized materials were characterized using x-ray diffraction, Fourier-transform infrared, UV–Vis diffuse reflectance spe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanotechnology 2022-11, Vol.33 (47), p.475603
Hauptverfasser: Thao, Vu Dinh, Dung, Nguyen Trung, Ha, Nguyen Thu, Minh, Ho Ngoc, Duong, Hung Cong, Van Nguyen, To, Son, Luong Trung, Huy, Nguyen Nhat, Thu, Tran Viet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A novel silver@silver chloride/carbon nanofiber (Ag@AgCl/CNF) hybrid was synthesized by electrospinning, heat treament, and subsequent in situ chemical oxidation strategy. The synthesized materials were characterized using x-ray diffraction, Fourier-transform infrared, UV–Vis diffuse reflectance spectroscopy, scanning electron microscopy, and energy dispersive x-ray. The experimental results reveal that the electrospun AgNO 3 /PAN was carbonized and reduced to Ag/CNF, the Ag/CNF was then partly oxidized to form Ag@AgCl/CNF in which Ag@AgCl nanoparticles (ca. 10–20 nm in diameter) were uniformly bounded to CNFs (ca. 165 nm in diameter). The obtained Ag@AgCl/CNF was employed for Na 2 S 2 O 8 activation under visible light irradiation to treat Rhodamine B (RhB). A remarkable RhB removal of ca. 94.68% was achieved under optimal conditions, and the influence of various parameters on removal efficiency was studied. Quenching experiments revealed that HO•, SO 4 •− , 1 O 2 , and O 2 •− were major reactive oxygen species, in which O 2 •− played a pivotal role in RhB degradation. A possible mechanistic route for RhB degradation was proposed.
ISSN:0957-4484
1361-6528
DOI:10.1088/1361-6528/ac86db